AIBS 2018 is the fifth and latest edition of the Survey. In addition to AIBS’ core questions, in 2018 we featured two special areas of focus: Latin America and the use of new technology and ecommerce to drive export sales.
- Future outlook for respondent’s business fundamentals was very strong, leading to positive knock-on effect on employment, with 72% planning to increase
headcount in Australia as a result;
- Four-in five respondents earned international revenue from more than one market, typically four-to-five markets;
- United States (25%), China (19%), New Zealand (14%), and the United Kingdom (14%) were the most important markets for respondents, by international
- Increasing use of digital/mobile technology and online channels was a focus for one-third of respondents, but still some way to go as another third were not planning to do so.
Become A Member
Co-Founder & Commercial Director,
Pharmako Biotechnologies Pty Ltd
Member of the ECA
"Pharmako Biotechnologies were already exporting when we joined the ECA. We joined to assist our export strategies, and unashamedly to promote ourselves
through the Australian Export Awards. As a small business, third party recognition and industry membership assist when dealing with large
Established in 1970, Mavlab Animal Health Pty Ltd is a Queensland based, family-owned, GMP licenced manufacturer of veterinary pharmaceuticals and pet care products. Mavlab has an extensive range of prescription and over the counter products sold in a growing number of global markets. Contract manufacturing opportunities are also available.